New York City, NY -- (SBWIRE) -- 01/14/2014 -- To receive alerts before the crowd, please take 7 seconds to sign up for our Premium SMS Alerts. Grab your cell phone and text the word "PICKS" to "555888”.
StockMarketIntel.com issues a special report on the following stocks: Geron Corporation (NASDAQ:GERN), The Bon-Ton Stores, Inc. (NASDAQ:BONT), Corcept Therapeutics Incorporated (NASDAQ:CORT), BG Medicine, Inc. (NASDAQ:BGMD)
Geron Corporation (NASDAQ:GERN) declined -13.79%, trading on 8.46 million shares, to end the trade at $4.50. The stock changed hands in a range of $4.47 to $5.24, bringing its market capitalization to about $580.35 million. If we look at its trading history of the past 52 weeks, the share price suffered a low of $0.98 and was moved to the maximum level of $7.79. Geron Corporation (Geron) is a clinical-stage biopharmaceutical company developing a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. Telomerase is an enzyme that enables cancer cells to maintain telomere length, which provides them with the capacity for limitless cellular replication. Imetelstat is a specific inhibitor of telomerase.
Has GERN Found The Bottom and Ready To Move Up? Find Out Here
The Bon-Ton Stores, Inc. (NASDAQ:BONT) declined -13.48%, to complete the trading session at $13.41, with a total volume of 1.83 million shares. The stock, on average, trades on a volume of 272,068 shares. It floated in a range of $12.70 to $13.83 during the last trading session, with a beta value of 2.94. Its market capitalization now moved to about $274.52 million. In the past 52 weeks, the share price has not declined below $9.90 and above $22.68. The Bon-Ton Stores, Inc. is a department store operators in the United States, offering an assortment of apparel and accessories for women, men and children. The Company’s merchandise offerings also include cosmetics, home furnishings and other goods. The Company operates in two segments: Stores and eCommerce (its Internet websites).
Has BONT Found The Bottom And Ready To Gain Momentum? Find Out Here
Corcept Therapeutics Incorporated (NASDAQ:CORT) recorded a fall of -13.07% and was in a range of $3.15-$3.52 before closing at $3.26. The stock completed the day with a total volume of 1.15 million shares, versus an average volume of 429,365 shares. The share price hit its 52-week low of $1.47 and $3.83 was the best price. Corcept Therapeutics Inc is a United States-based pharmaceutical company. The Company is involved in the discovery and development of drugs that regulate the effects of cortisol or also known as the stress hormone. Founded on 1998, it has focused its research and clinical development activity on drugs that block the glucocorticoid receptor or GR-II receptor, one of the bodys two receptors of cotrisol.
Why Should Investors Buy CORT After the Recent Fall? Just Go Here and Find Out
BG Medicine, Inc. (NASDAQ:BGMD) declined -11.18% yesterday, bringing its market capitalization around $37.69 million. The share price, after opening at $1.53, made a high of $1.58 and hovered above $1.34 to end the day at $1.35. The total number of shares that changed hands during the session was 1.69 million shares, as compared to average trading volume of 3.11 million shares. BG Medicine, Inc. (BG Medicine) is a life sciences company focused on the discovery, development and commercialization of cardiovascular diagnostics to addresses unmet medical needs. The Company focuses on blood-based tests. Its lead product candidate in development is CardioSCORE, which is a multi-analyte biomarker-based blood test for atherothrombotic cardiovascular disease, commonly known as vulnerable plaque.
Will BGMD Get Buyers Even After The Recent Rally? Find Out Here
To receive alerts before the crowd, please take 7 seconds to sign up for our Premium SMS Alerts. Grab your cell phone and text the word "PICKS" to "555888”.
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)